Processing Magazine

Pfizer ordered to pay $45 million in menopause drug case

January 5, 2012

NEW YORK — An appeals court has ordered Pfizer Inc. to pay more than $45 million in damages to two women who claimed they developed breast cancer after taking the company’s menopause drugs, Bloomberg reported.

More than 6 million women took Prempro and related menopause drugs to treat symptoms including hot flashes and mood swings before a 2002 study highlighted their links to cancer, the article stated.

At one point, Pfizer and its units faced more than 10,000 lawsuits over the medications.

“We are very disappointed with the court’s decisions in these cases and continue to believe there was no basis in fact or law for the jury verdicts,” Chris Loder, a spokesman for New York-based Pfizer, said.